Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0X3LD
|
||||
Former ID |
DIB005598
|
||||
Drug Name |
Valtorcitabine
|
||||
Synonyms |
Epcitabine; Torcitabine; LDC-300; NV-02C; L-2-deoxycytidine; Val-L-dC; Beta-L-2`-deoxycytidine; L-dC prodrug, Idenix/Novartis; L-dC, Idenix/Novartis
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Hepatitis virus infection [ICD9: 573.3; ICD10:K75.9] | Discontinued in Phase 2 | [547183] | ||
Company |
Idenix Pharmaceuticals
|
||||
Structure |
Download2D MOL |
||||
Formula |
C14H22N4O5
|
||||
Canonical SMILES |
n1(c(=O)nc(cc1)N)[C@H]1O[C@H]([C@@H](C1)OC(=O)[C@@H](N)<br />C(C)C)CO
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | HBV polymerase | Target Info | Inhibitor | [528985] | |
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.